CRWD stock price outlook analysis: institutional divergence, bullish expectations moderate

2025-12-01 16:51:00

Oppenheimer maintains its “Outperform” rating on CrowdStrike (CRWD), but the pump potential is limited.

Price Targets vs Reality

The analysts' average target price is $512.28, which is only a pump of 2.19% compared to the latest closing price of $501.31—this rise is honestly not very attractive. The target price range is quite wide ($186.85-$741.30), indicating a significant disparity in market views on this stock.

There are some issues with the financial report expectations.

Good news: Expected annual revenue of $47.4 billion, with a quarter-on-quarter growth of 9.17%.

Bad news: The expected non-GAAP EPS is 3.94, which is a 17.77% decrease compared to the last forecast - this negative revision is worth noting.

Institutional Attitudes Begin to Loosen

2,994 funds/institutions hold positions, a decrease of 19 in the last quarter. Although the average portfolio share increased from 0.42% to 0.43%, the total number of shares held by institutions actually dropped by 5.30% to 198 million shares—this is a contradictory signal.

The bearish/bullish ratio is 1.07, slightly pessimistic.

What Are Big Players Doing

Increased: Vanguard's Total Stock Market Fund and S&P 500 Fund both increased their holdings in CRWD, with an increase of over 32%.

Reducing positions: JPMorgan, Geode Capital, and Jennison are all reducing their investment in CRWD (by 50%-90%), with Jennison directly cutting 7.15% of its shares.

Bottom line: Although there are endorsements from influential institutions, the reduction of holdings by leading funds is more concerning. This stock may no longer be the darling of institutions.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.